Trial intelligence / Profile preview

Salsalate for Insulin Sensitivity in Obese Non-Diabetics

NCT00339833Phase 4Completed

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases
Start
Mar 2003
Primary completion
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Amigesic in type 2 diabetes mellitus (T2DM), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Mar 2003; status: completed.

02

Drugs

Amigesic
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00339833.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00339833.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call